- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Email this article to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Evans, S. K.
- Articles by Lundblad, V.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Evans, S. K.
- Articles by Lundblad, V.
The Est1 Subunit of Saccharomyces cerevisiae Telomerase Makes Multiple Contributions to Telomere Length Maintenance
Sara K. Evansa and Victoria Lundbladaa Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030
Corresponding author: Victoria Lundblad, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030., lundblad{at}bcm.tmc.edu (E-mail)
Communicating editor: L. PILLUS
| ABSTRACT |
|---|
The telomerase-associated Est1 protein of Saccharomyces cerevisiae mediates enzyme access by bridging the interaction between the catalytic core of telomerase and the telomere-binding protein Cdc13. In addition to recruiting telomerase, Est1 may act as a positive regulator of telomerase once the enzyme has been brought to the telomere, as previously suggested by the inability of a Cdc13-Est2 fusion protein to promote extensive telomere elongation in an est1-
strain. We report here three classes of mutant Est1 proteins that retain association with the telomerase enzyme but confer different in vivo consequences. Class 1 mutants display a telomere replication defect but are capable of promoting extensive telomere elongation in the presence of a Cdc13-Est2 fusion protein, consistent with a defect in telomerase recruitment. Class 2 mutants fail to elongate telomeres even in the presence of the Cdc13-Est2 fusion, which is the phenotype predicted for a defect in the proposed second regulatory function of EST1. A third class of mutants impairs an activity of Est1 that is potentially required for the Ku-mediated pathway of telomere length maintenance. The isolation of mutations that perturb separate functions of Est1 demonstrates that a telomerase holoenzyme subunit can contribute multiple regulatory roles to telomere length maintenance.
TELOMERES, the ends of chromosomes, are composed of duplex G-rich repeat sequences that terminate in single-strand 3' extensions. Maintenance of both the length and the terminal structure of telomeres is crucial for genomic integrity and, consequently, for long-term cell viability. The telomerase enzyme is a key factor involved in telomere length maintenance (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Telomere length maintenance requires not only a functional telomerase enzyme, but also a proficient pathway for mediating enzyme access to the end of the chromosome (for review, see ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
A recent study has further investigated the roles of Est1, Est2, and Cdc13 in telomere replication, by monitoring the association of each of these proteins with chromosome termini, using chromatin immunoprecipitation (ChIP) with a subtelomeric probe that detects sequences located between
350 and 600 bp from the end of the chromosome (![]()
![]()
![]()
The Est1 protein also potentially contributes to telomere replication through nucleic acid interactions. Partially purified recombinant Est1 protein from Escherichia coli binds both single-strand RNA and DNA in vitro (![]()
![]()
![]()
![]()
![]()
![]()
To correlate the biochemical activities of Est1interaction with Cdc13, telomeric DNA, and the telomerase holoenzymewith the proposed roles based on in vivo analysis, we have subjected the Est1 protein to a detailed site-directed mutational analysis. Analysis of 30 est1 mutants, which introduced missense mutations into 74 residues of the 699-aa Est1 protein, has yielded several distinct classes of separation-of-function mutations. Three classes of mutations encode Est1 proteins that retain association with an active telomerase complex, but confer different in vivo phenotypic consequences for telomere replication. The first (and largest) class exhibits genetic properties indicating that this set of mutant proteins is defective in a step involved in enzyme recruitment. A second class of mutations fulfills criteria predicted for a defect in the putative second function: these mutants fail to elongate telomeres in the presence of the Cdc13-Est2 fusion, despite retaining association with the telomerase enzyme. A third set of mutants exhibits extremely short telomeres but no associated senescence phenotype; epistasis analysis suggests that this class defines an activity of EST1 that is potentially required for the Ku-mediated pathway of telomere length maintenance. We also report a cluster of mutations in the N-terminal region of Est1 that substantially reduce the association with the telomerase RNP and thus potentially define a domain required for stabilizing the Est1-TLC1 association. The identification of distinct classes of separation-of-function mutants, which associate with an active telomerase enzyme but appear to perturb different aspects of Est1 function, supports the proposal that Est1 has multiple roles in telomere replication.
| MATERIALS AND METHODS |
|---|
Yeast strains:
Isogenic strains TVL409, TVL415, TVL418, and TLV474 were derived from the protease-deficient strain AVL78 and were used for all experiments in Fig 2; 4A; 5, AC; and 6. TVL409 [MATa est1-
::kanR leu2 trp1 ura3-52 prb prc pep4-3/pVL232 (CEN URA3 EST1)] and TVL474 [MATa myc3-EST2 est1-
::kanR leu2 trp1 ura3-52 prb prc pep4-3/pVL232 (CEN URA3 EST1)] were constructed from AVL78 and TVL291 (![]()
![]()
::LEU2 leu2 trp1 ura3-52 prb prc pep4-3 /pSD120 (CEN URA3 TLC1)] was constructed from TLV415 by one-step gene disruption to remove nucleotides (nt) 2851008 of TLC1.
|
|
Two isogenic haploid strains, TVL471 [MAT
yku70-
::kanR est1-
::HIS3 ura3-52 ade2-101 lys2-801 leu2-
1 trp1-
1 his3-
200/pVL232 (CEN URA3 EST1)] and TVL304 [MATa yku80-
::kanR ura3-52 ade2-101 lys2-801 leu2-
1 trp1-
1 his3-
200/pVL867 (CEN URA3 YKU80)], were used for the experiments shown in Fig 3 and Fig 5D; both strains are related to the TVL120 strain background used in previous publications from this laboratory (![]()
![]()
cdc13-
/pVL438 (CEN URA3 CDC13) strain was generated by tetrad dissection of DVL336 (est1-
::HIS3/EST1 cdc13-
::LYS2/CDC13 ura3-52/ura3-52 ade2-101/ade2-101 lys2-801/lys2-801 leu2-
1/leu2-
1 trp1-
1/trp1-
1 his3-
200/his3-
200/pVL438).
|
|
|
Construction of EST1 mutations:
Two epitope-tagged versions of the Est1 protein were used in this work. Missense mutations were initially constructed in pVL1007 (derived from pRS415), with HA3-EST1 expressed from the native EST1 promoter; this HA3-EST1 construct has been shown previously to be fully functional when integrated into the genome (![]()
![]()
strain, presumably due to variations in plasmid copy number specific to this vector (data not shown). In addition, the HA3 tag did not achieve high-efficiency recovery during immunoprecipitations (typically
12% of the telomerase RNA). Therefore, a second parental plasmid (pVL1355, derived from YCplac22) was constructed, which introduced an myc18 epitope onto the C terminus of Est1, with EST1-myc18 expressed from the native EST1 promoter. This plasmid fully complemented an est1-
strain as assessed by several different assays (see Fig 2 Fig 3 Fig 4 for a comparison between EST1 and EST1-myc18). Furthermore, the presence of the myc18 epitope greatly increased Est1 IP efficiency (typically 1030% of TLC1). The 19 mutations that showed a potential defect when analyzed in the pVL1007 construct were subcloned into pVL1355, and the subcloned
1.6-kb region was completely sequenced for each mutant allele to rule out the possibility of potential additional unlinked mutations. All of the in vivo and in vitro analyses presented in this article, unless noted otherwise, were performed with the pVL1355-derived constructs. Nine mutant alleles (est1-32, est1-33, est1-35, est1-37, est1-40, est1-43, est1-44, est1-58, and est1-59) that showed no defect (or only very modest effects) on telomere length, when analyzed in the slightly less functional pVL1007 backbone, were not subcloned into pVL1355 for further analysis. The est1-
19 deletion mutation was generated by oligo-directed single-strand mutagenesis in pVL198, resulting in the deletion of aa 499518 (T. LENDVAY and V. LUNDBLAD, unpublished data), and was subsequently cloned into pVL1355.
For the overexpression studies presented in Fig 5D, mutations were subcloned into pVL1008 (derived from the 2µ pRS424 plasmid) with the HA3-EST1 gene expressed by the strong ADH promoter. Construction of plasmids expressing the Cdc13-Est2 (pVL1107) and HA3-Cdc13-Est2 (pVL1115) fusion proteins has been previously described (![]()
Cloning the Saccharomyces carlsbergensis EST1 gene:
Genomic DNA prepared from a strain of S. carlsbergensis (ATCC no. 2345) was digested with EcoRI and probed at low stringency with the S. cerevisiae EST1 gene, which detected a faint hybridizing 2.0-kb band. Preparative amounts of EcoRI-digested S. carlsbergensis DNA in the 1.9- to 2.1-kb size range were gel purified and cloned into pBluescript SK+. Approximately 1000 E. coli transformants containing this size-fractionated library were screened by low-stringency hybridization, and a single clone containing a 2.0-kb insert (pVL259) that encoded a gene with homology to S. cerevisiae EST1 was recovered. The S. carlsbergensis EST1 sequence has been deposited in GenBank under the accession no.
AF411028.
Genetic characterization of mutants:
Multiple (typically two to three) yeast isolates from each transformation were analyzed for growth, as described below, and telomere length, as described previously (![]()
strain background, plasmids expressing each est1-myc18 mutant were transformed into strain TVL471 at 30°. Transformants were inoculated into a 2-ml culture that maintained selection for both EST1 plasmids, plated at 10-fold serial dilutions onto -Trp -Ura and -Trp 5-FOA plates, and incubated for 23 days at 30°. For analysis of overexpression growth phenotypes, plasmids overexpressing the est1 mutations (on a 2µ plasmid and expressed as N-terminally tagged HA3 proteins from the strong ADH promoter) were introduced into TVL304. Following eviction of the covering YKU80 plasmid, colonies were resuspended in 100 µl of water and plated at equivalent cell counts at 10-fold serial dilutions onto -Trp plates that were subsequently incubated at 30°.
Biochemical characterization of mutants:
Cultures (initiated from est1-
strains expressing plasmid-borne est1-myc18 mutations immediately following the loss of the wild-type EST1 covering plasmid) were grown at 30° in selective media and harvested at an OD600 of 0.61.0. Extracts were prepared as described previously (![]()
![]()
![]()
30 times the amount loaded in the crude lane, and the efficiency of RNA recovery was quantitated by PhosphorImager analysis. For Western analysis, Est1-myc18 proteins were visualized using the 9E10 anti-myc antibody, horseradish peroxidase-conjugated goat anti-mouse antibody and ECL-Plus reagent (Amersham, Arlington Heights, IL). The amount of protein loaded into each lane varied by less than twofold, as measured by Bradford assay. Chain-terminating telomerase assay reactions were performed as described previously (![]()
| RESULTS |
|---|
Alignment of two Est1 homologs identifies conserved charged residues as targets for mutagenesis:
For the majority of the mutant alleles analyzed in this article, selection of amino acids for mutation relied on a comparison of the S. cerevisiae Est1 protein sequence with that from a related budding yeast species, Saccharomyces carlsbergensis. A genomic
2.0-kb fragment containing most of the S. carlsbergensis EST1 gene was recovered by reduced-stringency hybridization (see MATERIALS AND METHODS for details). This incomplete clone, which lacks N-terminal sequences, encodes an open reading frame that exhibits 59% aa identity to the S. cerevisiae Est1 protein over 551 amino acids (corresponding to aa 149699 of the S. cerevisiae protein). The highest degree of sequence identity (75%) lies within the 130-aa region that harbors the DNA- and RNA-binding activities (![]()
Regions of conservation between the two Est1 homologs were used to dictate the choice of residues to mutate, on the basis of a clustered charged-to-alanine scanning mutagenesis strategy. In this method, small groups of charged aa (which are likely to be located on the solvent-accessible surface of the protein) are mutated to alanine (![]()
![]()
![]()
In addition, seven additional mutations were examined that were not constructed on the basis of the charged cluster criteria (Fig 1B). These single aa missense mutations were targeted to a completely conserved block of residues, from aa 498 to 514 (located within the 130-aa domain required for DNA and RNA binding). Since basic and aromatic groups have been implicated in direct nucleic acid interaction (![]()
![]()
![]()
Missense mutations in the central 130-aa region of Est1 have a severe telomere replication defect:
The 30 clustered and single mutant alleles were subjected to a battery of in vivo phenotypic assays to determine effects on growth and telomere length maintenance. The panel was first tested for whether any mutations exhibited a senescence phenotype comparable to that of an est1-
null mutation. Plasmids harboring the est1 mutations (in single copy and expressed by the native EST1 promoter) were transformed into a haploid est1-
strain that harbored a covering EST1 plasmid. Following eviction of the wild-type EST1 plasmid, the collection of mutant strains was analyzed for a senescence phenotype (see MATERIALS AND METHODS for details). The results are summarized in Table 1, and data for a subset of mutant strains propagated for
75 or
100 generations are shown in Fig 2. Strains bearing six mutations, which all resided within the central 130-aa region of the protein, displayed a detectable senescence phenotype, indicating that EST1 function was severely impaired. Four mutant strains (bearing est1-7, est1-47, est1-48, or est1-52 alleles) displayed a senescence phenotype indistinguishable from that of an est1-
null strain, and two additional mutant strains (containing the est1-6 and est1-55 mutations) exhibited a moderate senescence phenotype (Fig 2).
|
A more stringent assay, capable of detecting partial defects in the telomerase-mediated pathway for telomere replication, was also used to examine the panel of 30 mutants. We have shown previously that a strain bearing null mutations in both telomerase and the Ku heterodimer exhibits greatly accelerated senescence, compared to the slower senescence displayed by a telomerase-defective strain (![]()
![]()
or yku80-
strain can provide a sensitized background for detecting intermediate reductions in the activity of a telomerase subunit. We introduced each of the 30 est1 mutations into a haploid est1-
yku70-
/pEST1 CEN URA3 strain and examined the strains for growth following eviction of the wild-type EST1 plasmid (Fig 3 and data not shown). As expected, the 6 est1 mutants described above that displayed moderate to severe senescence in a YKU70 background exhibited a further reduction in viability when combined with a yku70-
mutation. Five additional mutant strains with lesions that also mapped to the 130-aa central domain exhibited either severe (est1-46, est1-49, and est1-54) or partial (est1-50 and est1-51) reduction in viability in the yku70-
background. Three additional mutants located within this region (est1-53, est1-56, and est1-57) had little or no defect in either growth assay (Fig 2 and Fig 3). Thus, of the 14 missense mutations that were introduced into this 130-aa domain, 11 conferred a notable growth defect by either or both of these two assays. Only a single mutation (est1-42) that mapped outside the 130-aa region displayed a reduction in EST1 function that was sufficient to confer growth defect: although the est1-42 strain did not exhibit a senescence phenotype in a YKU70 background (Fig 2), a proliferative defect was observed in the est1-42 yku70-
strain (Fig 3).
The 30 mutations were also tested for their effects on telomere length. Plasmids expressing the est1 alleles were introduced into an est1-
/pEST1 CEN URA3 strain and telomere length was analyzed
60 generations following loss of the covering EST1 plasmid. Mutations in the 130-aa domain displayed the most severe reductions in telomere length (many were comparable to an est1-
strain), while mutations outside of this region showed more modest reductions in telomere length (Fig 4A). All of the 12 mutations described above that exhibited growth defects in either the YKU70 or the yku70-
strain backgrounds also displayed telomere lengths that were significantly shortened.
An unexpected conclusion from this initial phenotypic analysis was that 18 of the 30 missense mutationsa strikingly large numbershowed little or no effect on telomere length, with a corresponding lack of a discernable effect in either of the two growth assays. Eleven mutant strains exhibited telomere length comparable to that of wild type, and 7 additional mutations resulted in only modest effects on telomere length (Fig 4A and data not shown; summarized in Table 1 as class 4 and class 5 mutations). This may be a consequence of the emphasis placed on charged residues for mutagenesis; a similar rationale may also explain why mutant phenotypes were restricted primarily to the highly basic 130-aa domain.
Est1 proteins with missense mutations in the central 130-amino-acid region still retain association with telomerase:
One explanation for an in vivo defect in telomere replication could be a reduced association of a mutant Est1 protein with the telomerase holoenzyme complex. To test this, each mutant Est1 protein was examined for the ability to co-immunoprecipitate the TLC1 telomerase RNA subunit (Fig 5A and data not shown); a subset was also tested for association with enzyme activity (Fig 5B). Notably, 13 of the 14 mutations introduced into the 130-aa central domain retained roughly wild-type levels of association with telomerase (Fig 5; Table 1), indicating that the telomere replication defect displayed by these mutant proteins was not due to a gross inability to associate with the enzyme complex. The remaining mutant in this region, Est1-48, appeared to be reduced for telomerase association (Fig 5A and Fig B); however, both protein levels and the degree of association with TLC1 varied significantly from experiment to experiment (data not shown). The biochemical nature of this variability is unknown, but may reflect an unstable protein that is particularly susceptible to proteolysis in cell-free extracts (Fig 5C); the est1-48 mutation was therefore excluded from further analysis. The majority of the remaining mutant Est1 proteins exhibited a degree of interaction with telomerase roughly comparable to that of the wild-type Est1 protein; several notable exceptions are discussed in later sections.
The panel of est1 mutants was further examined by an additional in vivo assay that also potentially monitored association with the telomerase complex, by asking whether overexpression of these mutant proteins could influence telomere replication. We have previously shown that increasing the levels of wild-type Est1 protein results in a slight increase in telomere length, whereas overexpression of the Est1-6 and Est1-7 mutant proteins in a wild-type strain results in a modest telomere length decline (![]()
EST1 strain: in this sensitizing strain background, overexpression of either est1-6 or est1-7 results in a clear growth defect (![]()
EST1 strain. Collectively, 8 of the 14 mutations in the 130-aa domain conferred an overexpression dominant negative phenotype by this assay, whereas no mutations outside this region exhibited such a phenotype (Fig 5D and data not shown; summarized in Table 1). These 8 mutations also reduced telomere length when these mutant proteins were overexpressed in a YKU80 strain (![]()
mutation. On the basis of both telomere length defects and impaired growth in the two yku-dependent assays shown in Fig 3 and Fig 5D, these 8 mutants have been placed into a single class, referred to as class 1 in Table 1.
Identification of a class of mutations defective for the proposed second function of EST1:
We have previously observed that in an est1-
strain, the Cdc13-Est2 fusion fails to promote the extensive telomere elongation that occurs in the presence of Est1 (![]()
![]()
In contrast, two alleles, est1-42 and est1-
19, failed to promote extensive telomere elongation by the Cdc13-Est2 fusion. (The est1-
19 mutation, which removes amino acids 499518, is described in more detail in a later section in this article.) These two mutant alleles are therefore defective in this proposed second function, as defined by this genetic test, and thus constitute a second class of mutant alleles, referred to as class 2 in Table 1. Protein levels in these two mutant strains were not noticeably impaired (Fig 5C), although a moderate reduction in the association with telomerase was observed (see Table 1). However, other mutant proteins (Est1-38, Est1-39, and Est1-41, discussed in a later section of this article) displayed an even greater reduction in the ability to associate with telomerase, but were still able to promote extensive telomere elongation in the presence of the Cdc13-Est2 fusion protein (Table 1; Fig 4B). This argues that the failure of the Est1-42 or Est1-
19 proteins to promote telomere elongation in the presence of the Cdc13-Est2 fusion could not be attributed to a reduced interaction with the telomerase enzyme.
A third class of mutations defines an activity of EST1 that is potentially required for the Ku-mediated pathway of telomere length maintenance:
In the analysis described above, there was generally a good correlation between telomere length and growth: mutants with the shortest telomeres also displayed the most severe growth defects. However, two mutants (est1-50 and est1-51) were striking exceptions to this observation. Telomere length in these two strains was as short as that of an est1-
null strain (Fig 4A), and yet neither of these strains exhibited even a weak senescence phenotype (Fig 2). This lack of correlation between telomere length and a growth phenotype argued that the inability to maintain telomere length in these two strains was not due to a defect in the same activity that is lost in class 1 mutants. Furthermore, both est1-50 and est1-51 promoted telomere elongation in the presence of the Cdc13-Est2 fusion (Fig 4B), indicating that they are proficient for the proposed second function of EST1. Thus, these two alleles appear to define a functionally distinct class of est1 mutations, perturbing an activity of EST1 different from that altered in the other two classes of mutations discussed in the previous sections; these alleles are designated as class 3 mutants (Table 1).
In addition, est1-50 and est1-51 exhibited only a slightly impaired growth defect when placed in combination with a yku70-
mutation, in contrast to all other mutations that conferred short or very short telomeres (Fig 3). Furthermore, increased expression of Est1-50 and Est1-51 did not affect the growth of a yku80-
strain (Fig 5D). This epistasis behavior is reminiscent of that of a mutation in another subunit in telomerase: the tlc1-48 allele impairs an activity of TLC1 that has been proposed to interact, either directly or indirectly, with the Ku heterodimer to facilitate telomere length maintenance (![]()
Mutations in the N terminus of Est1 result in reduced association with telomerase:
Previous work demonstrated that deletion of the 130-aa central region completely abolished in vitro RNA-binding activity (![]()
In contrast, three mutations that mapped to the N-terminal region of the Est1 protein displayed a markedly reduced association with telomerase (class 4 in Table 1). All three proteins were greatly reduced for the ability to co-immunoprecipitate a TLC1-containing complex: Est1-38 (<2% of wild type, which is at the detection limit for these experiments), Est1-39 (3% of wild type), and Est1-41 (28% of wild type; Fig 5A; Table 1). These three mutants were similarly reduced for the presence of telomerase activity in the immunoprecipitates (Fig 5B). This reduced association with telomerase was not a result of decreased protein levels or reduced IP efficiency (Fig 5C and data not shown). In addition, this defect was not specific for the C-terminal myc18-tagged versions, as IP experiments with these three mutant proteins bearing an HA3 epitope at the N terminus were similarly reduced for association with telomerase (data not shown).
However, despite the significant reduction in telomerase association observed in these co-immunoprecipitation experiments, est1-38, est1-39, and est1-41 mutant strains did not exhibit any detectable defects in telomere replication. Telomere length was only slightly reduced in the est1-38 and est1-39 alleles and unaffected in the est1-41 mutant strain (Fig 4A), and none of these mutant strains exhibited any growth defects in the assays shown in Fig 2, Fig 3, and Fig 5D. These three mutants also displayed only minor reductions in the ability to promote telomere elongation in the presence of the Cdc13-Est2 fusion (Fig 4B). Potential explanations for the lack of correlation with an in vivo telomere replication defect are considered in DISCUSSION.
The Est1 protein fails to associate with telomerase in the absence of TLC1:
Previous biochemical analysis has shown that the Est1 and Est2 proteins co-immunoprecipitate (![]()
strains. The ProA-Est2 protein was immunoprecipitated, and the IP complex was assayed for the presence of Est1-myc18 by Western analysis. Although the Est1-myc18 protein could readily be detected in a ProA-Est2 IP in the presence of TLC1, it failed to co-immunoprecipitate with ProA-Est2 in tlc1-
cells (Fig 6A). This was not due to a gross destabilization of either Est1 or Est2 in the absence of TLC1 (data not shown; see also Fig 6B and ![]()
|
One possible mechanism to explain the above observation is that TLC1 functions as a "scaffold" onto which Est1 and Est2 bind, with Est1 and Est2 bound to distinct sites on the TLC1 RNA and held in proximity like beads on a string. In this model, the bridge between the two proteins is lost in the absence of the telomerase RNA. However, the recent finding that TLC1 may be required for assembly of the telomerase enzyme adds a layer of complexity to this model. The TLC1 RNA has binding sites for Sm proteins, suggesting that telomerase is assembled through a multistep pathway (![]()
strain, a telomerase complex may not be assembled. To address this, extracts were prepared from TLC1 cells and incubated in either the presence or the absence of RNaseA during the course of the immunoprecipitation; this method allowed for assembly of the telomerase complex prior to removal of the telomerase RNA. Fig 6B shows that the amount of Est1-myc18 protein present in the ProA-Est2 IP was substantially reduced upon RNaseA treatment. This was not due to destabilization of the Est1 protein in the absence of TLC1, as Est1 levels were unchanged in RNaseA-treated vs. untreated extracts. Thus, the presence of TLC1 is required for a stable association between Est1 and Est2 proteins. These results, in combination with prior observations that Est1 and Est2 independently associate with TLC1 (![]()
![]()
![]()
A previously proposed RNA recognition motif in Est1 is not required for association with telomerase:
The above observation indicates that the association of Est1 with the catalytic core is through a direct interaction with the telomerase RNA subunit. During the course of this analysis, the Futcher lab reported the presence of a potential RRM within the 130-aa central domain of Est1 and proposed that this sequence motif was required for TLC1 binding (![]()
![]()
To address this discrepancy further, we assessed the ability of an Est1 mutant protein deleted for the entire putative RNP-1 motif and adjacent residues (est1-
19, deleted from aa 499 to 518) to associate with telomerase. Deletion of these 20 amino acids resulted in a complete telomere replication defect, comparable to that of an est1-
null strain (Fig 2 Fig 3 Fig 4). However, the Est1-
19 mutant protein retained substantial association with a TLC1-containing complex (Fig 5A) and with a catalytically active enzyme (Fig 5B). Thus, removal of the putative RNA-binding motif does not abolish the ability of the mutant Est1 protein to interact with the telomerase RNA, arguing against a significant role for this region of the Est1 protein in the association with telomerase.
| DISCUSSION |
|---|
The Est1 protein is an essential regulatory component of the telomerase holoenzyme. Previous work has shown that a primary function of this subunit is to recruit telomerase to chromosome termini, in collaboration with the telomere binding protein Cdc13 (![]()
![]()
![]()
![]()
![]()
Identification of est1 mutants defective in the telomerase recruitment function:
Although class 1 mutants display a severe telomere replication defect, the inability to elongate telomeres is bypassed by the introduction of a Cdc13-Est2 fusion protein. This argues that the defect in this class of mutants occurs either at a step prior to or at the recruitment step. The behavior of these mutants is consistent with previous work demonstrating that Est1 mediates the association between the catalytic core of telomerase and the telomere (![]()
![]()
![]()
![]()
70-aa region of the Est1 protein. Similarly, a 15-kD domain of Cdc13 is sufficient for telomerase recruitment (![]()
This 70-aa region also overlaps with the 130-aa stretch of Est1 that has been previously implicated in nucleic acid binding. This region, spanning from aa 435 to aa 565, was defined by screening relatively large deletions for the ability to bind telomeric DNA in vitro (![]()
Identification of mutations that disrupt a step that occurs subsequent to telomerase recruitment:
Two est1 mutant strains display a telomere replication defect that cannot be bypassed by the presence of the Cdc13-Est2 fusion. The behavior of these two alleles recapitulates the phenotype of an est1-
strain carrying the Cdc13-Est2 fusioneven though the requirement for the Est1 recruitment function is alleviated, telomeres are not fully elongated (![]()
19, that display the same characteristics.
Although the est1-42 mutant strain is completely defective for the ability to promote Cdc13-Est2-dependent telomere elongation, this strain exhibits only a partial defect in telomere replication in an otherwise wild-type background (i.e., one that lacks the Cdc13-Est2 fusion): telomeres are short, although not as short as those of an est1-
null strain (Fig 4A), and an est1-42 strain does not exhibit a senescence phenotype (Fig 2). The phenotype of the est1-42 mutant strain argues that this second activity contributes to telomere length maintenance, but this contribution is not as critical as the Est1-mediated telomerase recruitment function. This is consistent with our prior observations showing that a Cdc13-Est2 fusion, which alleviates the requirement for the recruitment function of Est1, maintains viability of an est1-
strain (![]()
/Cdc13-Est2 strain should have instead displayed a full telomere replication defect.
The est1-
19 mutant also falls into this class on the basis of the inability to elongate telomeres in the presence of the Est2-Cdc13 fusion. However, this strain exhibits a more severe phenotype than does the est1-42 mutant strain. We suggest that est1-
19 may not be a complete separation-of-function allelein other words, both the proposed second function and other Est1-mediated activities may be impaired by this mutation (which is consistent with the fact that this deletion removes residues altered in the class 1 mutants).
Since the defining phenotype for this proposed second function is the inability of the catalytic core to extensively elongate telomeres when telomerase is tethered to the telomere as a Cdc13-Est2 fusion, the proposed second function of Est1 may mediate enzyme catalysis in some way. However, in the absence of a biochemical defect for the est1-42 mutant, models for this activity remain speculative at this point. For example, the est1-42 mutation may impair either DNA or RNA binding (on the basis of the assumption that additional determinants that contribute to nucleic acid binding may lie outside of the 130-aa domain). Thus, the second function of Est1 may be to promote accessibility of the 3' terminus to the active site of telomerase by virtue of its DNA-binding activity. Alternatively, the est1-42 mutant may exert its effects through an interaction with the RNA subunit, influencing parameters such as an inability to effectively position the templating RNA. Either model predicts that the telomerase holoenzyme should display altered enzymatic properties in the absence of the Est1 subunit, such as reduced ability of the primer to interact with the enzyme active site. Although the Est1 protein is dispensable for catalytic activity in vitro (![]()
![]()
Identification of mutations that define a potential third role for EST1 in telomere length maintenance:
Two mutant strains (est1-50 and est1-51) do not manifest a senescence phenotype, even though telomeres appear to be as short as those of an est1-
null strain, and thus these two strains fall into a third mutant class. However, an alternative possibility is that these two mutations are hypomorphic class 1 alleles, such that telomere length in these two strains is not quite reduced to that of a null mutation (but the slight difference cannot be detected on the Southern blot shown in Fig 4). Thus, there might be sufficient activity in the est1-50 and est1-51 mutants to maintain telomeres just barely above the length that would confer an obvious growth defect. Furthermore, est1-50 and est1-51, which disrupt aa 499 and 501, respectively, overlap with a class 1 mutation [est1-49 (R499A E500A)].
However, the phenotype of the est1-50 and est1-51 mutations in a yku80-
background clearly distinguishes these two alleles from class 1 mutations. Class 1 alleles confer a complete synthetic growth defect when combined with a yku70-
mutation. In contrast, the two class 3 mutations show only a minor growth defect in the yku70-
epistasis test, despite the fact that these two class 3 mutant strains have shorter telomeres than do many of the class 1 alleles (for example, compare telomere length of the est1-50 and est1-51 strains with the more moderate telomere length defects of est1-46, est1-55, and est1-7 strains).
Recent work from the Gottschling laboratory has shown that a 48-nt stem-loop structure in the TLC1 component of telomerase influences telomere length through the same pathway as Ku (![]()
strain. Furthermore, overexpression of the stem-loop structure did not exacerbate the telomere phenotype of a yku-
strain. The similar behavior of the est1-50 and est1-51 mutations prompts our suggestion that Est1 may also be involved in this same pathway. Additional work will be required to determine whether this is due to a direct role or whether this effect is exerted indirectly through the RNA subunit.
Residues comprising a putative RRM motif are not required for TLC1 binding:
One goal of this mutational analysis was to determine if mutations in the 130-aa domain, previously shown to be required for in vitro RNA binding, were defective for association in vivo with the holoenzyme. Strikingly, none of the mutants in this central region significantly affect the ability of the mutant Est1 protein to associate with the telomerase RNA, as all Est1 mutants in this region co-immunoprecipitate with the telomerase RNA at levels comparable to that of the wild-type Est1 protein. It is possible that multiple weak interactions in this region may contribute to RNA binding, so that disruption of one or two of the contacts is not sufficient to alter the association between Est1 and TLC1.
The results presented in this article also contradict the results presented by the Futcher laboratory regarding the functionality of the putative RNP-1 motif (![]()
An N-terminal region is required for interaction with telomerase:
Although mutations in the 130-aa domain that had lost association with TLC1 were not recovered, three mutants that map to the N terminus (est1-38, est1-39, and est1-41) show substantially reduced association with telomerase. Unexpectedly, these mutants do not display discernable defects in telomere replication. It is possible that the immunoprecipitation results reflect an in vivo decrease in the association of Est1 with telomerase in these three mutant strains. If so, this would suggest that substantial reductions in the ability of a mutant Est1 protein to associate with the telomerase enzyme have little negative consequences on telomere replication. Alternatively, the substantial reduced association with telomerase may be an in vitro artifact of the stringent immunoprecipitation conditions employed in these experiments. Thus, a partially weakened association between the mutant Est1 protein and telomerase might not result in a detectable in vivo phenotype, but might translate to a significant reduction during immunoprecipitation conditions (possibly due to loss of additional associated proteins). Notably, these three mutants cluster in a region spanning
115 aa near the amino terminus of the protein. Additional mutagenesis is in progress to test whether this region represents a direct Est1-TLC1-binding interface.
Future perspective:
This study, as well as several recent investigations (![]()
![]()
![]()
![]()
| ACKNOWLEDGMENTS |
|---|
We thank Alex Rhode and Kathleen Becherer for isolating the S. carlsbergensis EST1 homolog, Tom Lendvay for constructing the est1-
19 mutation, and Danna Morris for assistance in planning the site-directed mutagenesis. We also thank Kathy Friedman and Bruce Futcher for generously providing plasmids and members of the Lundblad laboratory, Thomas Cech, and several anonymous reviewers for helpful discussions and comments on the manuscript. This work was supported by a U.S. Army Medical Research and Materiel Command Breast Cancer Research Pre-doctoral Fellowship to S.K.E. and National Institutes of Health grant AG11728 grant to V.L.
Manuscript received November 30, 2001; Accepted for publication August 26, 2002.
| LITERATURE CITED |
|---|
BASS, S. H., M. G. MULKERRIN, and J. A. WELLS, 1991 A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc. Natl. Acad. Sci. USA 88:4498-4502.
BENNETT, W. F., N. F. PAONI, B. A. KEYT, D. BOTSTEIN, and A. J. JONES et al., 1991 High resolution analysis of functional determinants on human tissue-type plasminogen activator. J. Biol. Chem. 266:5191-5201.
COHN, M. and E. H. BLACKBURN, 1995 Telomerase in yeast. Science 269:396-400.
COLLINS, K., 2000 Mammalian telomeres and telomerase. Curr. Opin. Cell Biol. 12:378-383.[Medline]
COUNTER, C. M., M. MEYERSON, E. N. EATON, and R. A. WEINBERG, 1997 The catalytic subunit of yeast telomerase. Proc. Natl. Acad. Sci. USA 94:9202-9207.
DRAPER, D. E., 1999 Themes in RNA-protein recognition. J. Mol. Biol. 293:255-270.[Medline]
DUBRANA, K., S. PERROD, and S. M. GASSER, 2001 Turning telomeres off and on. Curr. Opin. Cell Biol. 13:281-289.[Medline]
EVANS, S. K., 2000 Analysis of EST1 and CDC13 as regulators of telomerase access in Saccharomyces cerevisiae. Ph.D. Thesis, Baylor College of Medicine, Houston.
EVANS, S. K. and V. LUNDBLAD, 1999 Est1 and Cdc13 as comediators of telomerase access. Science 286:117-120.
EVANS, S. K. and V. LUNDBLAD, 2000 Positive and negative regulation of telomerase access to the telomere. J. Cell Sci. 113:3357-3364.[Abstract]
FRIEDMAN, K. L. and T. R. CECH, 1999 Essential functions of amino-terminal domains in the yeast telomerase catalytic subunit revealed by selection for viable mutants. Genes Dev. 13:2863-2874.
GIBBS, C. S. and M. J. ZOLLER, 1991 Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. J. Biol. Chem. 266:8923-8931.
HUGHES, T. R., 1998 Biochemical characterization of telomere replication proteins in Saccharomyces cerevisiae. Ph.D. Thesis, Baylor College of Medicine, Houston.
HUGHES, T. R., S. K. EVANS, R. G. WEILBAECHER, and V. LUNDBLAD, 2000 The Est3 protein is a subunit of yeast telomerase. Curr. Biol. 10:809-812.[Medline]
JONES, S., D. T. DALEY, N. M. LUSCOMBE, H. M. BERMAN, and J. M. THORNTON, 2001 Protein-RNA interactions: a structural analysis. Nucleic Acids Res. 29:943-954.
KUNKEL, T. A., J. D. ROBERTS, and R. A. ZAKOUR, 1987 Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.[Medline]
LENDVAY, T. S., D. K. MORRIS, J. SAH, B. BALASUBRAMANIAN, and V. LUNDBLAD, 1996 Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144:1399-1412.[Abstract]
LINGNER, J., T. R. HUGHES, A. SHEVCHENKO, M. MANN, and V. LUNDBLAD et al., 1997a Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276:561-567.
LINGNER, J., T. R. CECH, T. R. HUGHES, and V. LUNDBLAD, 1997b Three Ever Shorter Telomere (EST) genes are dispensable for in vitro yeast telomerase activity. Proc. Natl. Acad. Sci. USA 94:11190-11195.
LIVENGOOD, A. J., A. J. ZAUG, and T. R. CECH, 2002 Essential regions of Saccharomyces cerevisiae telomerase RNA: separate elements for Est1p and Est2p interaction. Mol. Cell. Biol. 22:2366-2374.
LUNDBLAD, V. and J. W. SZOSTAK, 1989 A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57:633-643.[Medline]
MCEACHERN, M. J., A. KRAUSKOPF, and E. H. BLACKBURN, 2000 Telomeres and their control. Annu. Rev. Genet. 34:331-358.[Medline]
MARCAND, S., V. BREVET, C. MANN, and E. GILSON, 2000 Cell cycle restriction of telomere elongation. Curr. Biol. 10:487-490.[Medline]
MORRIS, D. K. and V. LUNDBLAD, 1997 Programmed translational frameshifting in a gene required for yeast telomere replication. Curr. Biol. 7:969-976.[Medline]
NUGENT, C. I., T. R. HUGHES, N. F. LUE, and V. LUNDBLAD, 1996 Cdc13p: a single-strand telomeric DNA-binding protein with a dual role in yeast telomere maintenance. Science 274:249-252.
NUGENT, C. I., G. BOSCO, L. ROSS, S. K. EVANS, and A. P. SALINGER et al., 1998 Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr. Biol. 8:657-660.[Medline]
O'REILLY, M., S. A. TEICHMANN, and D. RHODES, 1999 Telomerases. Curr. Opin. Struct. Biol. 9:56-65.[Medline]
PENG, Y., I. S. MIAN, and N. F. LUE, 2001 Analysis of telomerase processivity: mechanistic similarity to HIV-1 reverse transcriptase and role in telomere maintenance. Mol. Cell 7:1201-1211.[Medline]
PENNOCK, E., K. BUCKLEY, and V. LUNDBLAD, 2001 Cdc13 delivers separate complexes to the telomere for end protection and replication. Cell 104:387-396.[Medline]
PETERSON, S. E., A. E. STELLWAGEN, S. J. DIEDE, M. S. SINGER, and Z. W. HAIMBERGER et al., 2001 The function of a stem-loop in telomerase RNA is linked to the DNA repair protein Ku. Nat. Genet. 27:64-67.[Medline]
PRESCOTT, J. and E. H. BLACKBURN, 1997 Telomerase RNA mutations in Saccharomyces cerevisiae alter telomerase action and reveal nonprocessivity in vivo and in vitro. Genes Dev. 11:528-540.
QI, H. and V. A. ZAKIAN, 2000 The Saccharomyces telomere-binding protein Cdc13p interacts with both the catalytic subunit of DNA polymerase alpha and the telomerase-associated Est1 protein. Genes Dev. 14:1777-1788.
SETO, A. G., A. J. ZAUG, S. G. SOBEL, S. L. WOLIN, and T. R. CECH, 1999 Saccharomyces cerevisiae telomerase is an Sm small nuclear ribonucleoprotein particle. Nature 401:177-180.[Medline]
SINGER, M. S. and D. E. GOTTSCHLING, 1994 TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 266:404-409.
STEINER, B. R., K. HIDAKA, and B. FUTCHER, 1996 Association of the Est1 protein with telomerase activity in yeast. Proc. Natl. Acad. Sci. USA 93:2817-2821.
TAGGART, A. K., S.-C. TENG, and V. ZAKIAN, 2002 Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science 297:1023-1026.
VIRTA-PEARLMAN, V., D. K. MORRIS, and V. LUNDBLAD, 1996 Est1 has the properties of a single-stranded telomere end-binding protein. Genes Dev. 10:3094-3104.
ZHOU, J., K. HIDAKA, and B. FUTCHER, 2000 The Est1 subunit of yeast telomerase binds the Tlc1 telomerase RNA. Mol. Cell. Biol. 20:1947-1955.
This article has been cited by other articles:
![]() |
L. H. Bechard, B. D. Butuner, G. J. Peterson, W. McRae, Z. Topcu, and M. J. McEachern Mutant Telomeric Repeats in Yeast Can Disrupt the Negative Regulation of Recombination-Mediated Telomere Maintenance and Create an Alternative Lengthening of Telomeres-Like Phenotype Mol. Cell. Biol., February 1, 2009; 29(3): 626 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Yu, O. Steinberg-Neifach, A. T. Dandjinou, F. Kang, A. J. Morrison, X. Shen, and N. F. Lue Regulation of Telomere Structure and Functions by Subunits of the INO80 Chromatin Remodeling Complex Mol. Cell. Biol., August 15, 2007; 27(16): 5639 - 5649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hsu, E. Y. Yu, S. M. Singh, and N. F. Lue Mutual Dependence of Candida albicans Est1p and Est3p in Telomerase Assembly and Activation Eukaryot. Cell, August 1, 2007; 6(8): 1330 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bianchi and D. Shore Increased association of telomerase with short telomeres in yeast Genes & Dev., July 15, 2007; 21(14): 1726 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Steinberg-Neifach and N. F. Lue Modulation of telomere terminal structure by telomerase components in Candida albicans. Nucleic Acids Res., January 1, 2006; 34(9): 2710 - 2722. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lei, A. J. Zaug, E. R. Podell, and T. R. Cech Switching Human Telomerase On and Off with hPOT1 Protein in Vitro J. Biol. Chem., May 27, 2005; 280(21): 20449 - 20456. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Chappell and V. Lundblad Structural Elements Required for Association of the Saccharomyces cerevisiae Telomerase RNA with the Est2 Reverse Transcriptase Mol. Cell. Biol., September 1, 2004; 24(17): 7720 - 7736. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Zappulla and T. R. Cech From The Cover: Yeast telomerase RNA: A flexible scaffold for protein subunits PNAS, July 6, 2004; 101(27): 10024 - 10029. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grossi, A. Puglisi, P. V. Dmitriev, M. Lopes, and D. Shore Pol12, the B subunit of DNA polymerase {alpha}, functions in both telomere capping and length regulation Genes & Dev., May 1, 2004; 18(9): 992 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin and E. H. Blackburn Nucleolar protein PinX1p regulates telomerase by sequestering its protein catalytic subunit in an inactive complex lacking telomerase RNA Genes & Dev., February 15, 2004; 18(4): 387 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Bertuch and V. Lundblad The Ku Heterodimer Performs Separable Activities at Double-Strand Breaks and Chromosome Termini Mol. Cell. Biol., November 15, 2003; 23(22): 8202 - 8215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. SETO, K. UMANSKY, Y. TZFATI, A. J. ZAUG, E. H. BLACKBURN, and T. R. CECH A template-proximal RNA paired element contributes to Saccharomyces cerevisiae telomerase activity RNA, November 1, 2003; 9(11): 1323 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Singh and N. F. Lue Ever shorter telomere 1 (EST1)-dependent reverse transcription by Candida telomerase in vitro: Evidence in support of an activating function PNAS, May 13, 2003; 100(10): 5718 - 5723. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dahlen, P. Sunnerhagen, and T. S.-F. Wang Replication Proteins Influence the Maintenance of Telomere Length and Telomerase Protein Stability Mol. Cell. Biol., May 1, 2003; 23(9): 3031 - 3042. [Abstract] [Full Text] [PDF] |
||||
- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Email this article to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Evans, S. K.
- Articles by Lundblad, V.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Evans, S. K.
- Articles by Lundblad, V.












